The Circolo Hospital and Macchi Foundation is the largest hospital of Varese, Italy. Since 1995 is a hospital of national importance and high specialization. In 1975 it hosted the second faculty of Medicine of the University of Pavia, later incorporated in the new University of Insubria.

During the past decade, ASST Sette Laghi conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASST Sette Laghi" #1 sponsor was "Bayer" with 3 trials, followed by "Università degli Studi dell'Insubria" with 3 trials sponsored, "Fondazione Ricerca Traslazionale" with 2 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASST Sette Laghi" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator, "Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani" with 1 trials as a collaborator and "OPIS s.r.l" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "ASST Sette Laghi" are "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "CLL Transformation" (1 trials), "Covid19" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "ASST Sette Laghi" in a lesser frequency.

Most popular intervention types in "ASST Sette Laghi" are "Drug" (11 trials), "Other" (4 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ASST Sette Laghi" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ASST Sette Laghi". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in ASST Sette Laghi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ASST Sette Laghi, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

ASST Sette Laghi has several departments that took part in Clinical trials: "Department of Day Surgery Ospedale di Circolo Varese" - 5 trials, "Ospedale Di Circolo Galmarini, Cardiologia" - 3 trials, "Ospedale Di Circolo E Fondazione Macchi, Ssd Unita' Di Cure Intensive Coronariche" - 3 trials, "Ospedale Di Circolo E Fondazione Macchi - Cardiologia I" - 3 trials, "Ospedale Di Circolo E Fondazione Macchi; Oncologia Medica" - 2 trials